Table 2.
Use of adjunctive diuretics alongside loop diuretics.
| Of the occasions on which you administer loop diuretics to achieve a negative fluid balance, how often do you use the following agents (either as adjuncts or alternatives)? | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Always or nearly all of the time |
Frequently (>50% of the time) |
Sometimes (20–50% of the time) |
Rarely (<20% of the time) |
Never |
Total |
||||||
| N | % | N | % | N | % | N | % | N | % | N | |
| Thiazides (e.g. bendroflumethiazide) | 23 | (6.0%) | 32 | (8.4%) | 47 | (12.3%) | 121 | (31.6%) | 160 | (41.8%) | 383 |
| Potassium-sparing (e.g. spironolactone) | 10 | (2.6%) | 48 | (12.5%) | 115 | (29.9%) | 165 | (42.9%) | 47 | (12.2%) | 385 |
| Carbonic anhydrase inhibitors (e.g. acetazolamide) | 5 | (1.3%) | 10 | (2.6%) | 56 | (14.7%) | 163 | (42.8%) | 147 | (38.6%) | 381 |
| Answered | 393 | ||||||||||
| Skipped | 165 | ||||||||||